Meilleure Health International Industry Group Limited (HKG:2327)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2490
-0.0010 (-0.40%)
Jul 23, 2026, 3:58 PM HKT

HKG:2327 Cash Flow Statement

Millions HKD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
37.9832.4840.8317.8260.32
Depreciation & Amortization
1.11.632.63.793.55
Other Amortization
--0.040.060.03
Loss (Gain) From Sale of Assets
-0.27-0.06-0.48-0-
Asset Writedown & Restructuring Costs
-21.73-5.31-18.54-13.58-15.18
Loss (Gain) From Sale of Investments
5.32-19.38-5.7719.24-31.74
Loss (Gain) on Equity Investments
4.123.024.3514.7711.07
Stock-Based Compensation
0.050.19-1.02-0.862.03
Provision & Write-off of Bad Debts
1.170.22.50.240.92
Other Operating Activities
-39.91-15.785.62-15.329.52
Change in Accounts Receivable
44.15199.5-165.8323.96-93.65
Change in Inventory
-91.67-26.11-0.79-1.85-18.41
Change in Accounts Payable
5.5319.98-5.55-5.21-11.66
Change in Other Net Operating Assets
4.15-4.385.550.1-0.07
Operating Cash Flow
-50.02186-136.4943.15-83.27
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.58-0.13-0.83-1.01-6.48
Sale of Property, Plant & Equipment
00.17-0.01-
Divestitures
----58.84
Sale (Purchase) of Intangibles
----0.04-0.04
Sale (Purchase) of Real Estate
3.7-15.57-32.25--
Investment in Securities
10.410.0539.28106.3395.9
Other Investing Activities
20.66-195.2317.567.0813.34
Investing Cash Flow
14.64-253.9853.72-134.76161.56

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
137.01126.5194.48141.2236.21
Total Debt Issued
137.01126.5194.48141.2236.21
Long-Term Debt Repaid
-78.31-106.26-36.31-51.16-25.47
Total Debt Repaid
-78.31-106.26-36.31-51.16-25.47
Net Debt Issued (Repaid)
58.720.2558.1790.0610.74
Repurchase of Common Stock
-8.86--0.34-37.02-40.68
Common Dividends Paid
-22.52-16.38-65.5--
Other Financing Activities
-9.25-10.26-11.23-11.11-8.28
Financing Cash Flow
18.07-6.39-18.941.93-38.22

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.45-1.99-3.01-11.93-0.95
Net Cash Flow
-16.87-76.37-104.68-61.639.12

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-50.6185.86-137.3242.14-89.75
Free Cash Flow Growth
-----
Free Cash Flow Margin
-138.57%366.77%-106.20%35.15%-35.47%
Free Cash Flow Per Share
-0.010.04-0.030.01-0.02
Levered Free Cash Flow
-340.47157.45-78.41-196.55189.31
Unlevered Free Cash Flow
-334.67163.88-71.28-189.4194.55

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
9.2510.2611.2311.118.28
Cash Income Tax Paid
1.510.089.889.8418.84
Change in Working Capital
-37.85189-166.6217-123.79